Cat. No. | Product name | CAS No. | Purity | Chemical Structure |
---|---|---|---|---|
T19480 | NO-prednisolone | 327610-87-7 | 99.31% |
|
NO-prednisolone (NCX-1015) is a compound that effectively stimulates the production of IL-10 in vivo. It is a Prednisolone derivative that releases nitric oxide ... | ||||
T3416 | Aucubin | 479-98-1 | 99.31% |
|
Aucubin (Rhinanthin) is an iridoid glycoside with anti-inflammatory, anti-microbial, anti-algesic as well as anti-tumor activities. | ||||
T11634 | IL-15-IN-1 | 1831830-20-6 | 99.28% |
|
IL-15-IN-1 is a selective and potent Interleukin 15 (IL-15) inhibitor, inhibiting the proliferation of IL-15-dependent cells (IC50: 0.8 μM). | ||||
T1846 | Y-320 | 288250-47-5 | 99.23% |
|
Y-320 is a new phenylpyrazoleanilide immunomodulator. | ||||
TN1996 | Nothofagin | 11023-94-2 | 99.21% |
|
Nothofagin has antioxidant, and antithrombotic activities, it possesses anti-inflammatory activity by inhibiting hyperpermeability, expression of CAMs, and adhes... | ||||
T4S0795 | Berberrubine chloride | 15401-69-1 | 99.11% |
|
1. Berberrubine chloride (9-Berberoline Chloride) has antitumor activity. 2. Berberrubine has antidiabetic activity. 3. Berberrubine dose-dependently inhibits IL... | ||||
T12218 | NFAT Transcription Factor Regulator-1 | 245747-71-1 | 99.11% |
|
NFAT Transcription Factor Regulator-1 is an synthesis inhibitor of IL-2 (IC50 of 182 nM). | ||||
T9930 | Secukinumab | 875356-43-7 | 99.10% |
Secukinumab
|
Secukinumab is a fully humanized monoclonal anti-IL-17A antibody and the first in its class to be approved by the US Food and Drug Administration for the treatme... | ||||
T41142 | EM 163 | 1206480-93-4 | 99.07% |
|
EM 163 is a TIR-TIR interaction inhibitor, which is a TIR (Toll/interleukin-1 receptor) structural domain mimic of the MyD88 protein. EM 163 targets the TIR stru... | ||||
TN1818 | Kaempferol 3-O-β-D-glucuronide | 22688-78-4 | 99.07% |
|
Kaempferol 3-O-β-D-glucuronide (Kaempferol-3-beta-O-glucuronide)e has antioxidant activity. Flavonoid glucuronides can be deconjugated by microsomal α²-glucuroni... | ||||
TN1894 | Luteolin-4'-O-glucoside | 6920-38-3 | 99.05% |
|
Luteolin-4'-O-glucoside (Luteolin-4-o-glucoside) is an inhibitor of IL-5 (IC50 = 3.7 μM) with anti-complementary, antioxidant and anticancer activity. | ||||
T38361 | GSK717 | 1595278-21-9 | 99.01% |
|
GSK717 is a potent, selective NOD2 (nucleotide-binding oligomerization domain 2) inhibitor. GSK717 inhibits muramyl dipeptide (MDP)-induced NOD2-mediated signali... | ||||
T0122 | Bergenin | 477-90-7 | 99.01% |
|
Bergenin (Bengenin) is a polyphenol, which is an effective antinarcotic agent with antioxidant action. | ||||
T2S2264 | Linalool | 78-70-6 | 98.95% |
|
1. Linalool (Linalol), a natural compound of the essential oils, has been shown to have antinociceptive, antimicrobial, and anti-inflammatory properties. 2. Lina... | ||||
TN1416 | Ayanin | 572-32-7 | 98.9% |
|
Ayanin has vasorelaxant activity, it also may have the potential for use in treating allergic asthma.The IC(50) value of Ayanin (quercetin-3,7,4'-O-trimethylethe... | ||||
T3830 | 20(R)-Ginsenoside Rg2 | 80952-72-3 | 98.89% |
|
20(R)-Ginsenoside Rg2 (20R-Ginsenoside Rg2) is a compound with anti-oxidant and anti-apoptosis. | ||||
TN2088 | Platycodin D2 | 66663-90-9 | 98.83% |
|
Platycodin D2 , a less hemolytic saponin, can improve specific cellular and humoral responses to hepatitis B surface antigen in mice, it could be safely used as ... | ||||
T14778 | BRD6989 | 642008-81-9 | 98.82% |
|
BRD6989 is an analog of the natural product cortistatin A (dCA). Which inhibits CDK8 and upregulates IL-10. BRD6989 inhibits the kinase activity of recombinant C... | ||||
TN1132 | Procyanidin A2 | 41743-41-3 | 98.78% |
|
Procyanidin A2 is a potential precursor of 5-(3',4'-dihydroxyphenyl)-γ-valerolactone, exhibits antioxidant, anti-inflammary, anti-hyperglycemia, and anti-type 2 ... | ||||
TN1579 | Dihydrocucurbitacin B | 13201-14-4 | 98.67% |
|
Dihydrocucurbitacin B (23,24-dihydrocucurbitacin B) is isolated from the roots of Cayaponia tayuya with anti-cancer activity. |